Correlation Between Novacyt SA and Aethlon Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Novacyt SA and Aethlon Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novacyt SA and Aethlon Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novacyt SA and Aethlon Medical, you can compare the effects of market volatilities on Novacyt SA and Aethlon Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novacyt SA with a short position of Aethlon Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novacyt SA and Aethlon Medical.

Diversification Opportunities for Novacyt SA and Aethlon Medical

0.4
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Novacyt and Aethlon is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Novacyt SA and Aethlon Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aethlon Medical and Novacyt SA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novacyt SA are associated (or correlated) with Aethlon Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aethlon Medical has no effect on the direction of Novacyt SA i.e., Novacyt SA and Aethlon Medical go up and down completely randomly.

Pair Corralation between Novacyt SA and Aethlon Medical

Assuming the 90 days horizon Novacyt SA is expected to generate 0.93 times more return on investment than Aethlon Medical. However, Novacyt SA is 1.08 times less risky than Aethlon Medical. It trades about 0.03 of its potential returns per unit of risk. Aethlon Medical is currently generating about 0.0 per unit of risk. If you would invest  82.00  in Novacyt SA on September 19, 2024 and sell it today you would lose (12.00) from holding Novacyt SA or give up 14.63% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Novacyt SA  vs.  Aethlon Medical

 Performance 
       Timeline  
Novacyt SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Novacyt SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Aethlon Medical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aethlon Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, Aethlon Medical is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Novacyt SA and Aethlon Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Novacyt SA and Aethlon Medical

The main advantage of trading using opposite Novacyt SA and Aethlon Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novacyt SA position performs unexpectedly, Aethlon Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aethlon Medical will offset losses from the drop in Aethlon Medical's long position.
The idea behind Novacyt SA and Aethlon Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing